Douglas Levermore | Beyond Borders: The Healthcare Business Opportunity for Jamaica

“Wherever the art of medicine is loved, there is also a love of humanity.” — attributed to Hippocrates

In an increasingly interconnected world, the movement of people is no longer driven solely by leisure, commerce, or migration, but by the search for affordable, competent healthcare.

 Across continents, individuals are boarding planes not for beaches, but for operating theatres, rehabilitation centres, and specialised clinics that promise outcomes, affordability, or timeliness that may not be available at home. What was once a niche segment of global travel has matured into a structured and competitive industry, with health tourism emerging as one of the more quietly transformative forces in both healthcare delivery and economic development.

Health tourism has evolved into a multi-billion-dollar global industry with strong forward momentum, generating tens of billions annually and projected to expand rapidly over the next decade, according to estimates from global market research firms such as Grand View Research and McKinsey. Estimates place the market at roughly $40–50 billion today, with projections ranging from $150 billion to over $250 billion by the early 2030s, driven by rising healthcare costs in developed countries and increased demand for affordable, high-quality care abroad. When combined with the broader wellness tourism segment—which already exceeds $600 billion globally—the economic footprint becomes even more significant, underscoring the sector’s role as a high-value contributor to the travel, healthcare, and service economies.

 Beyond direct revenues, the industry delivers powerful spillover effects across hospitality, transportation, pharmaceuticals, and professional services, positioning health tourism not merely as a niche market, but as a strategic economic pillar for countries that are able to structure and capture it effectively.

Health tourism reflects a simple but powerful imbalance. Demand for timely, high-quality, and affordable care continues to outpace supply in many developed systems, where long waiting times, high costs, and capacity constraints have become defining features. At the same time, a number of countries have invested deliberately in building medical capacity that exceeds domestic demand, positioning themselves as destinations for international patients. 

The convergence of these dynamics has created a marketplace where care is no longer strictly local, but increasingly global.

The success stories are not accidental nor isolated. Countries such as Mexico, Thailand, India, and Turkey have, over the past two decades, built robust and viable health tourism ecosystems anchored by internationally accredited hospitals, competitive pricing structures, and integrated patient experiences that extend well beyond the clinical encounter. Patients are not simply purchasing a procedure; they are purchasing certainty, coordination, and trust. These countries have aligned clinical quality, regulatory oversight, travel logistics, hospitality infrastructure, and branding into cohesive systems that make the patient journey seamless and reliable.

Consider Mexico, for example, which has developed a strong and demonstrably credible track record in bariatric surgery, attracting thousands of international patients each year, particularly from the United States. Its success in weight loss surgery has been built on a combination of competitive pricing, experienced surgeons, internationally accredited facilities, and geographic proximity that reduces both travel time and logistical complexity. Patients are often able to access procedures at a fraction of the cost they would face domestically, while still receiving high-quality care within structured, patient-focused systems. The result is not only a steady inflow of medical tourists but a broader ecosystem of recovery services, accommodation and follow-up care that reinforces Mexico’s position as a leading destination in this specialised segment of health tourism.

The economic implications extend well beyond the hospital walls. Health tourism generates spillover effects across hospitality, transportation, pharmaceuticals, and professional services, creating clusters of economic activity that resemble specialised service ecosystems. Research from global tourism bodies consistently shows that medical tourists spend significantly more per visit than traditional leisure tourists, reflecting the high-value nature of care-related travel and positioning the sector as a premium segment within the broader tourism economy.

For private financiers, the opportunity lies not only in hospitals and clinics, but in the ecosystem that surrounds them. While tertiary facilities are capital-intensive and complex, adjacent investments such as diagnostic centres, outpatient surgical units, rehabilitation facilities, and recovery-focused accommodations offer more predictable returns and scalable models. Increasingly, value is also being created through technology platforms that support patient navigation, remote consultation, and post-treatment continuity of care, extending the health tourism experience beyond physical borders.

Jamaica enters this conversation with an advantage that many aspiring health tourism destinations do not possess: a mature and globally recognised tourism industry. The island welcomes millions of visitors annually and has spent decades building expertise in hospitality, transportation, accommodation, customer service, and destination marketing. In 2024, Jamaica recorded approximately 4.3 million visitor arrivals, including more than 2.9 million stopover visitors and over 1.4 million cruise passengers, generating roughly US$4.3 billion in tourism earnings. These figures represent far more than economic statistics. They reflect a sophisticated ecosystem of airports, hotels, attractions, logistics providers, restaurants, and service professionals that already understands how to receive, accommodate, and care for international guests. Health tourism does not require Jamaica to reinvent itself; it requires the country to leverage an existing competency and extend it into a higher-value segment where healthcare, hospitality, and wellness converge.

Within this evolving landscape, Jamaica’s opportunity does not lie in scale but in precision. The island is not required to compete head-on with established healthcare “giants”, but to position itself intelligently within high-value niches where it already holds natural advantages. 

The most immediate pathway lies in diaspora-focused healthcare, particularly among Jamaicans in the United States, Canada, and the United Kingdom, where cultural trust and emotional connection can meaningfully influence decision-making. For this segment, care is not purely transactional but relational, creating strong demand for services such as routine and complex dentistry, orthopaedic procedures, cardiac diagnostics, and chronic disease management, particularly when paired with recovery experiences that reconnect patients with family and environment.

Complementing this is a compelling opportunity in post-operative recovery and rehabilitation, where Jamaica’s climate, proximity to North America, and established hospitality sector can be leveraged to offer medically supervised recovery for patients treated abroad. Purpose-built recovery centres, physiotherapy hubs, and wellness-oriented accommodations can create a differentiated model that blends clinical oversight with restorative experience. This approach allows Jamaica to enter the value chain without immediately bearing the full cost and complexity of advanced surgical infrastructure.

In parallel, Jamaica is well positioned to expand into clinically grounded wellness and preventive care, moving beyond traditional spa tourism into structured programmes that deliver measurable health outcomes. Executive health screenings, lifestyle medicine, stress management retreats, and nutrition-based interventions already offer strong appeal to corporate clients and high-net-worth individuals seeking short, intensive, and results-driven experiences. This model can be extended thoughtfully into the management of chronic dependencies, including substance use disorders and emerging behavioural addictions such as digital overuse, where individuals increasingly seek discreet, restorative environments away from familiar triggers. Jamaica’s natural setting, combined with professionally supervised programmes that integrate medical oversight, psychological support, and evidence-based therapies, creates the potential for recovery experiences that are both clinically credible and holistically grounded. The opportunity, therefore, is to elevate wellness from leisure to legitimacy, positioning the island as a destination where prevention, recovery, and long-term behavioural change are supported by qualified practitioners, structured programmes, and outcomes that can be meaningfully measured.

From an investment perspective, the strongest opportunities are likely to emerge in mid-tier, scalable facilities rather than large, capital-heavy hospital builds. Diagnostic centres, outpatient facilities, dialysis units, and rehabilitation hubs offer shorter development timelines and more predictable demand, while integrated developments that combine care with accommodation and ancillary services can enhance both patient experience and revenue capture. Public-private partnerships will be critical in de-risking investment, particularly through streamlined regulatory frameworks, incentives for internationally accredited facilities, and the creation of designated health tourism zones that enable coordination across sectors.

Several internationally recognised organisations have demonstrated the viability of destination-based addiction recovery and clinically grounded wellness, including the Hazelden Betty Ford Foundation in the United States, The Priory Group in the United Kingdom, The Cabin Chiang Mai in Thailand, Paracelsus Recovery in Switzerland, and Acıbadem Healthcare Group in Turkey. These providers have built global reputations by combining clinical excellence with structured, discreet, and often retreat-style environments that attract international and high-net-worth patients, reinforcing the importance of credibility, accreditation, and patient experience in this segment.

Crucially, Jamaica must resist the temptation to pursue health tourism as a broad, undefined ambition. Success in this space is built on focus, credibility, and consistency. Attempting to offer everything risks diluting both investment and brand. By contrast, a targeted approach anchored in diaspora care, recovery and rehabilitation, and clinically grounded wellness allows the country to build reputation incrementally while generating early wins that can be reinvested into more complex offerings over time.

There is, finally, a strategic alignment that Jamaica is uniquely positioned to exploit. The island already understands tourism at a deep operational level, with a well-developed capacity for service delivery, experience design, and environmental appeal. Health tourism, at its best, sits at the intersection of these capabilities with clinical excellence. The opportunity, therefore, is not to build something entirely new, but to extend an existing strength into a higher-value domain.

Jamaica does not need to become the largest player in health tourism to be a successful one. It needs only to become a trusted destination for specific, high-value services, delivered consistently, supported by strong partnerships, and anchored in an experience that few others can replicate. 

In a global market defined by choice, trust, and outcomes, that may prove to be more than enough.

---

Douglas Levermore, MBA, JP, is an independent management consultant and the founding Executive Director of Jamaica’s Public Investment Management Secretariat (PIMSEC)—the government unit established to strengthen project appraisal, fiscal discipline, and oversight of public investment, now known as the Public Investment Appraisal Branch (PIAB) within the Ministry of Finance and the Public Service. He also serves as a FINRA arbitrator and a commissioned Notary Public in the Commonwealth of Virginia. With experience advising governments, international development partners, public bodies, and private-sector organisations on governance, public investment management, organisational performance, and strategic reform, Douglas brings a practical, results-oriented perspective to his writing on social issues, leadership, management lessons, and organisational strategy. He is available for select international consulting, advisory, keynote speaking, and project-based engagements and may be contacted at [email protected].